• 21 Citations
  • 2 h-Index
20172019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Nicola Orofino is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Primary Myelofibrosis Medicine & Life Sciences
Osteosclerosis Medicine & Life Sciences
Hematologic Neoplasms Medicine & Life Sciences
Leukemia, Myeloid, Chronic Phase Medicine & Life Sciences
Reticulin Medicine & Life Sciences
Acute Promyelocytic Leukemia Medicine & Life Sciences
Neutropenia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2019

  • 21 Citations
  • 2 h-Index
  • 13 Article
  • 4 Letter
1 Citation (Scopus)

Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study)

Elli, E. M., Iurlo, A., Aroldi, A., Caramella, M., Malato, S., Casartelli, E., Maffioli, M., Gardellini, A., Carraro, M. C., D'Adda, M., Polverelli, N., Rossi, M., Orofino, N., Carrer, A., Gambacorti-Passerini, C., Antolini, L. & Passamonti, F., Jan 1 2019, In : British Journal of Haematology. 186, 5, p. e123-e126

Research output: Contribution to journalLetter

Open Access
1 Citation (Scopus)

Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study

Fracchiolla, N. S., Sciumè, M., Orofino, N., Guidotti, F., Grancini, A., Cavalca, F., Freyrie, A., Goldaniga, M. C., Consonni, D., Mattiello, V., Pettine, L. & Cortelezzi, A., May 1 2019, In : PLoS One. 14, 5, e0216715.

Research output: Contribution to journalArticle

Open Access
Epidemiology
Hematologic Neoplasms
epidemiology
Antigens
Sodium Glutamate

Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach

Iurlo, A., Elli, E. M., Palandri, F., Cattaneo, D., Bossi, A., Cortinovis, I., Bucelli, C., Orofino, N., Brioschi, F., Auteri, G., Bianchi, P., Fabris, S., Isimbaldi, G., Sabattini, E., Baldini, L. & Gianelli, U., Jan 1 2019, In : Hematological Oncology. 37, 4, p. 424-433

Research output: Contribution to journalArticle

Primary Myelofibrosis
Mutation
Practice Management
Multicenter Studies
Survival

Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline

Crugnola, M., Castagnetti, F., Breccia, M., Ferrero, D., Trawinska, M. M., Abruzzese, E., Annunziata, M., Stagno, F., Tiribelli, M., Binotto, G., Bonifacio, M., Fava, C., Iurlo, A., Bucelli, C., Mansueto, G., Gozzini, A., Falzetti, F., Montefusco, E., Crisà, E., Gugliotta, G. & 24 others, Russo, S., Cedrone, M., RussoRossi, A., Pregno, P., Isidori, A., Mauro, E., Atelda, R., Giglio, G., Celesti, F., Sorà, F., Storti, S., D’Addosio, A., Galimberti, S., Orlandi, E., Calistri, E., Bocchia, M., Cavazzini, F., Rege Cambrin, G., Orofino, N., Luciano, L., Sgherza, N., Rosti, G., Latagliata, R. & Capodanno, I., Jan 1 2019, In : Annals of Hematology. 98, 10, p. 2329-2338

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Imatinib Mesylate
Cytogenetics
Disease-Free Survival
Disease Progression

Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline

Crugnola, M., Castagnetti, F., Breccia, M., Ferrero, D., Trawinska, M. M., Abruzzese, E., Annunziata, M., Stagno, F., Tiribelli, M., Binotto, G., Bonifacio, M., Fava, C., Iurlo, A., Bucelli, C., Mansueto, G., Gozzini, A., Falzetti, F., Montefusco, E., Crisà, E., Gugliotta, G. & 24 others, Russo, S., Cedrone, M., RussoRossi, A., Pregno, P., Isidori, A., Mauro, E., Atelda, R., Giglio, G., Celesti, F., Sorà, F., Storti, S., D'Addosio, A., Galimberti, S., Orlandi, E., Calistri, E., Bocchia, M., Cavazzini, F., Rege Cambrin, G., Orofino, N., Luciano, L., Sgherza, N., Rosti, G., Latagliata, R. & Capodanno, I., Oct 2019, In : Annals of Hematology. 98, 10, p. 2329-2338 10 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Imatinib Mesylate
Cytogenetics
Disease-Free Survival
Disease Progression